{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:24:04Z","timestamp":1777591444098,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Coffee consumption has been associated with various health benefits; however, the underlying biological mechanisms remain poorly understood. In particular, the acute effects of coffee on circulating cytokines and the specific role of caffeine compared with the whole coffee matrix are still insufficiently characterised in humans. To our knowledge, no previous human study has directly compared immune modulation by coffee versus caffeine alone. We therefore aimed to elucidate the effect of a usual caffeine dose of 130\u00a0mg on postprandial cytokine secretion, and whether responses differ between coffee and pure caffeine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a randomized pilot trial, ten healthy volunteers completed three test days receiving either a coffee brew, an aqueous caffeine solution (each 130\u00a0mg caffeine\/100\u00a0ml), or water. Quantitative analysis of caffeine was performed with UHPLC-MS\/MS, immune markers were measured by a multiplex immunoassay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study demonstrates that both caffeine and coffee consumption influence the immune homeostasis, albeit with notable differences on cytokine secretion. Pure caffeine induced a higher anti-inflammatory response, as evidenced by the significant decrease in pro-inflammatory cytokines such as IL-17\u00a0A, IL-12p70, and IL-2 compared to coffee and water. The integrated response on the immune system is exemplified by the decrease of the pro-inflammatory IFN-\u03b3 (0.649\u2009\u00b1\u20090.068) and the anti-inflammatory IL-10 (0.478\u2009\u00b1\u20090.043), vs. baseline, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings provide novel in vivo evidence that usual coffee and caffeine acutely affects cytokine responses differently in healthy individuals. In conclusion, our study addresses an important gap regarding the immune properties of coffee and suggests that bioactive compounds beyond caffeine contribute substantially to its immunological effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00394-026-03913-z","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T04:31:45Z","timestamp":1771216305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune modulation in response to coffee intake: a pilot study"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5304-0981","authenticated-orcid":false,"given":"M.","family":"Bleffgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0610-7186","authenticated-orcid":false,"given":"R.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8604-4889","authenticated-orcid":false,"given":"K.","family":"Rogal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-9245","authenticated-orcid":false,"given":"V.","family":"Somoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6875-1658","authenticated-orcid":false,"given":"Thomas","family":"Skurk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"3913_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/practneurol-2015-001162","volume":"16","author":"A Nehlig","year":"2016","unstructured":"Nehlig A (2016) Effects of coffee\/caffeine on brain health and disease: what should I tell my patients? Pract Neurol 16:89\u201395. https:\/\/doi.org\/10.1136\/practneurol-2015-001162","journal-title":"Pract Neurol"},{"key":"3913_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1550-2783-7-5","volume":"7","author":"ER Goldstein","year":"2010","unstructured":"Goldstein ER, Ziegenfuss T, Kalman D et al (2010) International society of sports nutrition position stand: caffeine and performance. J Int Soc Sports Nutr 7:5. https:\/\/doi.org\/10.1186\/1550-2783-7-5","journal-title":"J Int Soc Sports Nutr"},{"key":"3913_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2337\/dc13-1203","volume":"37","author":"M Ding","year":"2014","unstructured":"Ding M, Bhupathiraju SN, Chen M et al (2014) Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care 37:569\u2013586. https:\/\/doi.org\/10.2337\/dc13-1203","journal-title":"Diabetes Care"},{"key":"3913_CR4","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1001\/archinternmed.2009.439","volume":"169","author":"R Huxley","year":"2009","unstructured":"Huxley R, Lee CMY, Barzi F et al (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 169:2053\u20132063. https:\/\/doi.org\/10.1001\/archinternmed.2009.439","journal-title":"Arch Intern Med"},{"key":"3913_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/nutrit\/nuy014","volume":"76","author":"M Carlstr\u00f6m","year":"2018","unstructured":"Carlstr\u00f6m M, Larsson SC (2018) Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev 76:395\u2013417. https:\/\/doi.org\/10.1093\/nutrit\/nuy014","journal-title":"Nutr Rev"},{"key":"3913_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jacc.2013.06.035","volume":"62","author":"JH O\u2019Keefe","year":"2013","unstructured":"O\u2019Keefe JH, Bhatti SK, Patil HR et al (2013) Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol 62:1043\u20131051. https:\/\/doi.org\/10.1016\/j.jacc.2013.06.035","journal-title":"J Am Coll Cardiol"},{"key":"3913_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jama.294.1.97","volume":"294","author":"RM van Dam","year":"2005","unstructured":"van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294:97\u2013104. https:\/\/doi.org\/10.1001\/jama.294.1.97","journal-title":"JAMA"},{"key":"3913_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/10408390500400009","volume":"46","author":"JV Higdon","year":"2006","unstructured":"Higdon JV, Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101\u2013123. https:\/\/doi.org\/10.1080\/10408390500400009","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3913_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.113.005925","volume":"129","author":"M Ding","year":"2014","unstructured":"Ding M, Bhupathiraju SN, Satija A et al (2014) Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 129:643\u2013659. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005925","journal-title":"Circulation"},{"key":"3913_CR10","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00394-019-02009-1","volume":"59","author":"A Kuang","year":"2020","unstructured":"Kuang A, Erlund I, Herder C et al (2020) Targeted proteomic response to coffee consumption. Eur J Nutr 59:1529\u20131539. https:\/\/doi.org\/10.1007\/s00394-019-02009-1","journal-title":"Eur J Nutr"},{"key":"3913_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biopha.2017.10.064","volume":"97","author":"M Naveed","year":"2018","unstructured":"Naveed M, Hejazi V, Abbas M et al (2018) Chlorogenic acid (CGA): A Pharmacological review and call for further research. Biomed Pharmacother 97:67\u201374. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.064","journal-title":"Biomed Pharmacother"},{"key":"3913_CR12","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00394-017-1379-1","volume":"56","author":"N Tajik","year":"2017","unstructured":"Tajik N, Tajik M, Mack I et al (2017) The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature. Eur J Nutr 56:2215\u20132244. https:\/\/doi.org\/10.1007\/s00394-017-1379-1","journal-title":"Eur J Nutr"},{"key":"3913_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3945\/ajcn.2009.28548","volume":"91","author":"K Kempf","year":"2010","unstructured":"Kempf K, Herder C, Erlund I et al (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 91:950\u2013957. https:\/\/doi.org\/10.3945\/ajcn.2009.28548","journal-title":"Am J Clin Nutr"},{"key":"3913_CR14","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.pharmthera.2006.02.002","volume":"111","author":"LA Horrigan","year":"2006","unstructured":"Horrigan LA, Kelly JP, Connor TJ (2006) Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther 111:877\u2013892. https:\/\/doi.org\/10.1016\/j.pharmthera.2006.02.002","journal-title":"Pharmacol Ther"},{"key":"3913_CR15","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.imbio.2018.08.011","volume":"223","author":"T Al Reef","year":"2018","unstructured":"Al Reef T, Ghanem E (2018) Caffeine: Well-known as psychotropic substance, but little as Immunomodulator. Immunobiology 223:818\u2013825. https:\/\/doi.org\/10.1016\/j.imbio.2018.08.011","journal-title":"Immunobiology"},{"key":"3913_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s0014-2999(98)00619-0","volume":"358","author":"G Hask\u00f3","year":"1998","unstructured":"Hask\u00f3 G, N\u00e9meth ZH, Vizi ES et al (1998) An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice. Eur J Pharmacol 358:261\u2013268. https:\/\/doi.org\/10.1016\/s0014-2999(98)00619-0","journal-title":"Eur J Pharmacol"},{"key":"3913_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4049\/jimmunol.164.1.436","volume":"164","author":"AA Link","year":"2000","unstructured":"Link AA, Kino T, Worth JA et al (2000) Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol 164:436\u2013442. https:\/\/doi.org\/10.4049\/jimmunol.164.1.436","journal-title":"J Immunol"},{"key":"3913_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1046\/j.1365-3083.1997.d01-377.x","volume":"45","author":"A Eigler","year":"1997","unstructured":"Eigler A, Greten TF, Sinha B et al (1997) Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand J Immunol 45:132\u2013139. https:\/\/doi.org\/10.1046\/j.1365-3083.1997.d01-377.x","journal-title":"Scand J Immunol"},{"key":"3913_CR19","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.4049\/jimmunol.156.11.4408","volume":"156","author":"O Le Moine","year":"1996","unstructured":"Le Moine O, Stordeur P, Schanden\u00e9 L et al (1996) Adenosine enhances IL-10 secretion by human monocytes. J Immunol 156:4408\u20134414","journal-title":"J Immunol"},{"key":"3913_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1124\/jpet.105.096016","volume":"317","author":"LM Kreckler","year":"2006","unstructured":"Kreckler LM, Wan TC, Ge Z-D et al (2006) Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J Pharmacol Exp Ther 317:172\u2013180. https:\/\/doi.org\/10.1124\/jpet.105.096016","journal-title":"J Pharmacol Exp Ther"},{"key":"3913_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.bcp.2004.12.008","volume":"69","author":"JG Zhang","year":"2005","unstructured":"Zhang JG, Hepburn L, Cruz G et al (2005) The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes. Biochem Pharmacol 69:883\u2013889. https:\/\/doi.org\/10.1016\/j.bcp.2004.12.008","journal-title":"Biochem Pharmacol"},{"key":"3913_CR22","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0026-895X(25)10681-0","volume":"11","author":"JN Wells","year":"1975","unstructured":"Wells JN, Wu YJ, Baird CE et al (1975) Phosphodiesterases from Porcine coronary arteries: Inhibition of separated forms by xanthines, papaverine, and Cyclic nucleotides. Mol Pharmacol 11:775\u2013783","journal-title":"Mol Pharmacol"},{"key":"3913_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.intimp.2004.06.005","volume":"4","author":"LA Horrigan","year":"2004","unstructured":"Horrigan LA, Kelly JP, Connor TJ (2004) Caffeine suppresses TNF-alpha production via activation of the Cyclic AMP\/protein kinase a pathway. Int Immunopharmacol 4:1409\u20131417. https:\/\/doi.org\/10.1016\/j.intimp.2004.06.005","journal-title":"Int Immunopharmacol"},{"key":"3913_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0162-3109(92)90076-o","volume":"24","author":"LA Rosenthal","year":"1992","unstructured":"Rosenthal LA, Taub DD, Moors MA et al (1992) Methylxanthine-induced Inhibition of the antigen- and superantigen-specific activation of T and B lymphocytes. Immunopharmacology 24:203\u2013217. https:\/\/doi.org\/10.1016\/0162-3109(92)90076-o","journal-title":"Immunopharmacology"},{"key":"3913_CR25","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/sj.bjp.0702624","volume":"127","author":"DO Proc\u00f3pio","year":"1999","unstructured":"Proc\u00f3pio DO, Teixeira MM, Camargo MM et al (1999) Differential inhibitory mechanism of Cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli. Br J Pharmacol 127:1195\u20131205. https:\/\/doi.org\/10.1038\/sj.bjp.0702624","journal-title":"Br J Pharmacol"},{"key":"3913_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1128\/cdli.2.6.689-692.1995","volume":"2","author":"AM van Furth","year":"1995","unstructured":"van Furth AM, Seijmonsbergen EM, Langermans JA et al (1995) Effect of Xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes. Clin Diagn Lab Immunol 2:689\u2013692. https:\/\/doi.org\/10.1128\/cdli.2.6.689-692.1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"3913_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/pr.2016.50","volume":"80","author":"R Chavez-Valdez","year":"2016","unstructured":"Chavez-Valdez R, Ahlawat R, Wills-Karp M et al (2016) Mechanisms of modulation of cytokine release by human cord blood monocytes exposed to high concentrations of caffeine. Pediatr Res 80:101\u2013109. https:\/\/doi.org\/10.1038\/pr.2016.50","journal-title":"Pediatr Res"},{"key":"3913_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cyto.2004.12.013","volume":"30","author":"M Ritter","year":"2005","unstructured":"Ritter M, Hohenberger K, Alter P et al (2005) Caffeine inhibits cytokine expression in lymphocytes. Cytokine 30:177\u2013181. https:\/\/doi.org\/10.1016\/j.cyto.2004.12.013","journal-title":"Cytokine"},{"key":"3913_CR29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL et al (2016) Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res 25:1057\u20131073. https:\/\/doi.org\/10.1177\/0962280215588241","journal-title":"Stat Methods Med Res"},{"key":"3913_CR30","doi-asserted-by":"publisher","first-page":"e1800384","DOI":"10.1002\/mnfr.201800384","volume":"63","author":"MM Ulaszewska","year":"2019","unstructured":"Ulaszewska MM, Weinert CH, Trimigno A et al (2019) Nutrimetabolomics: an integrative action for metabolomic analyses in human nutritional studies. Mol Nutr Food Res 63:e1800384. https:\/\/doi.org\/10.1002\/mnfr.201800384","journal-title":"Mol Nutr Food Res"},{"key":"3913_CR31","doi-asserted-by":"crossref","unstructured":"Biesalski HK, Grimm P, Nowitzki-Grimm S (2017) Taschenatlas Ern\u00e4hrung, 7th edn. Georg Thieme Verlag KG","DOI":"10.1055\/b-005-143652"},{"key":"3913_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/beverages10010012","volume":"10","author":"B Brandl","year":"2024","unstructured":"Brandl B, Czech C, Wudy SI et al (2024) Validation of N-Methylpyridinium as a feasible biomarker for roasted coffee intake. Beverages 10:12. https:\/\/doi.org\/10.3390\/beverages10010012","journal-title":"Beverages"},{"key":"3913_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/beverages5020037","volume":"5","author":"J dePaula","year":"2019","unstructured":"dePaula J, Farah A (2019) Caffeine consumption through coffee: content in the Beverage, Metabolism, health benefits and risks. Beverages 5:37. https:\/\/doi.org\/10.3390\/beverages5020037","journal-title":"Beverages"},{"key":"3913_CR34","doi-asserted-by":"publisher","first-page":"752826","DOI":"10.3389\/fphar.2021.752826","volume":"12","author":"J Grzegorzewski","year":"2021","unstructured":"Grzegorzewski J, Bartsch F, K\u00f6ller A et al (2021) Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing. Front Pharmacol 12:752826. https:\/\/doi.org\/10.3389\/fphar.2021.752826","journal-title":"Front Pharmacol"},{"key":"3913_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T (2021) IL-6 in inflammation, autoimmunity and cancer. Int Immunol 33:127\u2013148. https:\/\/doi.org\/10.1093\/intimm\/dxaa078","journal-title":"Int Immunol"},{"key":"3913_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-94-024-0921-5_4","volume":"941","author":"T Tanaka","year":"2016","unstructured":"Tanaka T, Narazaki M, Masuda K et al (2016) Regulation of IL-6 in immunity and diseases. Adv Exp Med Biol 941:79\u201388. https:\/\/doi.org\/10.1007\/978-94-024-0921-5_4","journal-title":"Adv Exp Med Biol"},{"key":"3913_CR37","doi-asserted-by":"publisher","unstructured":"Skurk T, Kr\u00e4mer T, Marcinek P et al (2023) Sweetener system intervention shifted neutrophils from homeostasis to priming. Nutrients 15 https:\/\/doi.org\/10.3390\/nu15051260","DOI":"10.3390\/nu15051260"},{"key":"3913_CR38","doi-asserted-by":"publisher","first-page":"8921","DOI":"10.1073\/pnas.132556899","volume":"99","author":"K Ito","year":"2002","unstructured":"Ito K, Lim S, Caramori G et al (2002) A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A 99:8921\u20138926. https:\/\/doi.org\/10.1073\/pnas.132556899","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3913_CR39","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/s0006-2952(01)00613-x","volume":"61","author":"CI Ezeamuzie","year":"2001","unstructured":"Ezeamuzie CI (2001) Involvement of A(3) receptors in the potentiation by adenosine of the inhibitory effect of Theophylline on human eosinophil degranulation: possible novel mechanism of the anti-inflammatory action of Theophylline. Biochem Pharmacol 61:1551\u20131559. https:\/\/doi.org\/10.1016\/s0006-2952(01)00613-x","journal-title":"Biochem Pharmacol"},{"key":"3913_CR40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1124\/pr.117.014407","volume":"70","author":"A Nehlig","year":"2018","unstructured":"Nehlig A (2018) Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev 70:384\u2013411. https:\/\/doi.org\/10.1124\/pr.117.014407","journal-title":"Pharmacol Rev"},{"key":"3913_CR41","doi-asserted-by":"publisher","unstructured":"Nehlig A (2022) Effects of coffee on the Gastro-Intestinal tract: a narrative review and literature update. Nutrients 14. https:\/\/doi.org\/10.3390\/nu14020399","DOI":"10.3390\/nu14020399"},{"key":"3913_CR42","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.fct.2007.09.094","volume":"46","author":"WW Huber","year":"2008","unstructured":"Huber WW, Rossmanith W, Grusch M et al (2008) Effects of coffee and its chemopreventive components Kahweol and Cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem Toxicol 46:1230\u20131238. https:\/\/doi.org\/10.1016\/j.fct.2007.09.094","journal-title":"Food Chem Toxicol"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-026-03913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00394-026-03913-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-026-03913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:49:21Z","timestamp":1775663361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00394-026-03913-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3913"],"URL":"https:\/\/doi.org\/10.1007\/s00394-026-03913-z","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Procedures for this pilot intervention study were followed in accordance with the ethical standards of the Helsinki Declaration and were reviewed and approved by the ethics committee of the School of Medicine at the Technical University of Munich, Germany (5798\/13 S-SR). All study participants had provided written informed consent. The study was registered in the German Clinical Trials Register (DRKS: DRKS00005083).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"61"}}